Otrivin 1 mg/ml, nasal spray, solution. One ml of solution contains 1 mg of xylometazoline hydrochloride (Xylometazolini hydrochloridum). Excipient with known effect: Benzalkonium chloride. Each dose of the spray contains 0.014 mg of benzalkonium chloride, which corresponds to 0.1 mg of benzalkonium chloride in 1 ml of solution. The medicinal product facilitates the outflow of secretions from inflamed paranasal sinuses. By reducing congestion of the nasopharyngeal mucosa, it can be used as an adjunct to otitis media. Otrivin facilitates nasal examination. Otrivin is intended for use in adults and adolescents over 12 years of age. Responsible entity: GlaxoSmithKline Consumer Healthcare Sp. z oovI2023.
Otrivin for children 0.5 mg/ml, nasal spray, solution. One ml of solution contains 0.5 mg of xylometazoline hydrochloride (Xylometazolini hydrochloridum). Excipient with known effect: Benzalkonium chloride. Intended use. Excessive nasal congestion occurring in the course of colds, hay fever, allergic rhinitis, sinusitis. The medicinal product facilitates the outflow of secretions from inflamed paranasal sinuses. By reducing congestion of the nasopharyngeal mucosa, it can be used as an adjunct to otitis media. Otrivin for children facilitates nasal examination. Otrivin for children is intended for use in children aged 2 to 11 years. Responsible entity: GlaxoSmithKline Consumer Healthcare Sp. z o. o. v. I.2023.
Otrivin Menthol, 1 mg/ml, nasal spray, solution. One ml of solution contains 1 mg of xylometazoline hydrochloride. One dose of the spray contains 0.14 mg of xylometazoline hydrochloride. Excipients with known effect: 2.75 mg/ml macrogolglycerol hydroxystearate (polyoxylenated hydrogenated castor oil). intended use; excessive nasal congestion occurring in the course of colds, hay fever, allergic rhinitis, sinusitis. The medicinal product facilitates the outflow of secretions from inflamed paranasal sinuses. By reducing congestion of the nasopharyngeal mucosa, it can be used as an adjunct to otitis media. The product facilitates nasal examination. Otrivin Menthol is intended for use in adults and adolescents over 12 years of age. Responsible entity: GlaxoSmithKline Consumer Healthcare Sp. z o. o. v. I.2023.
